Not available
Quote | Evogene Ltd. (NASDAQ:EVGN)
Last: | $0.64 |
---|---|
Change Percent: | -4.6% |
Open: | $0.6663 |
Close: | $0.64 |
High: | $0.67 |
Low: | $0.62 |
Volume: | 178,871 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
News | Evogene Ltd. (NASDAQ:EVGN)
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants PR Newswire More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and ...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat PR Newswire Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 ...
Message Board Posts | Evogene Ltd. (NASDAQ:EVGN)
Subject | By | Source | When |
---|---|---|---|
Casterra Signs a Framework Agreement with a World | midastouch017 | investorshub | 06/21/2023 11:48:50 AM |
$EVGN MomentumIts gaining last trade up | Singhania | investorshub | 06/20/2023 5:31:10 AM |
short squeeze article | Fress | investorshub | 06/20/2023 1:54:11 AM |
short data if anyone is interested | midastouch017 | investorshub | 06/17/2023 12:25:22 PM |
$EVGN MomentumIts trading last trade up | Instrumentalist | investorshub | 06/17/2023 9:57:18 AM |
News, Short Squeeze, Breakout and More Instantly...
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants PR Newswire More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and ...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat PR Newswire Lavie Bio successfully completed testing of Yalos™ for winter wheat and will commence sales across the US for the 2024-2025 season REHOVOT, Israel , July 2, 2024 ...
2024-06-27 08:15:04 ET Alliance Global Partners analyst issues BUY recommendation for EVGN on June 27, 2024 07:06AM ET. The previous analyst recommendation was Buy. EVGN was trading at $0.6436 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...